Skip to main content

SENSORCAINE

NDC 63323-460 · Fresenius Kabi USA, LLC

Generic nameBUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE
Dosage formINJECTION, SOLUTION
RouteEPIDURAL, RETROBULBAR
Active ingredient(s)BUPIVACAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE
Strength7.5; .005 mg/mL; mg/mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
Marketing categoryNDA

Packages

63323-460-37 — 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-460-37) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-460-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51662-1638 — BUPIVACAINE HYDROCHLORIDE injection, solution, 55150-167 — Bupivacaine Hydrochloride, 55150-168 — Bupivacaine Hydrochloride, 55150-169 — Bupivacaine Hydrochloride, 55150-170 — Bupivacaine Hydrochloride, 55150-171 — Bupivacaine Hydrochloride, 55150-172 — Bupivacaine Hydrochloride, 55150-249 — Bupivacaine Hydrochloride, 55150-250 — Bupivacaine Hydrochloride, 55154-6970 — BUPIVACAINE HYDROCHLORIDE, 63323-461 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-462 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-463 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-464 — BUPIVACAINE HYDROCHLORIDE, 63323-465 — BUPIVACAINE HYDROCHLORIDE, 63323-466 — BUPIVACAINE HYDROCHLORIDE, 63323-467 — BUPIVACAINE HYDROCHLORIDE, 63323-468 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-472 — BUPIVACAINE HYDROCHLORIDE, 63323-481 — LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, +179 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels